This article shall be known and may be cited as the “Controlled Substances Therapeutic Research Act.” History. Code 1933, § 84-901A, enacted by Ga. L. 1980, p. 82, § 1; Ga. L. 2009, p. 859, § 1/HB 509. Cross references. Controlled substances generally, T. 16, C. 13. Care and treatment of cancer patients, T. 31, […]
The General Assembly finds and declares that the potential medicinal value of marijuana has received insufficient study due to a lack of financial incentives for the undertaking of appropriate research by private drug manufacturing concerns. Individual physicians cannot feasibly utilize marijuana in clinical trials because of federal governmental controls which involve expensive, time-consuming approval and […]
As used in this article, the term: “Board” means the Georgia Composite Medical Board. “Marijuana” means marijuana or tetrahydrocannabinol, as defined or listed in Article 2 of Chapter 13 of Title 16. “Physician” means a person licensed to practice medicine pursuant to Article 2 of this chapter. “Program” means the Controlled Substances Therapeutic Research Program […]
There is established under the Georgia Composite Medical Board the Controlled Substances Therapeutic Research Program, which shall be administered by the board. Under the program, the board shall act as a sponsor of state-wide investigational studies, utilizing as drug investigators individual physicians who elect to participate in accordance with the guidelines and protocols developed by […]
The board shall appoint the Patient Qualification Review Board. Each member of the review board shall be approved for such membership by a majority vote of the board and shall serve at the pleasure of the board. The review board shall be composed of: A board certified physician in ophthalmology; A board certified physician in […]
The board shall apply to contract with the National Institute on Drug Abuse for receipt of marijuana pursuant to this article and pursuant to regulations promulgated by the National Institute on Drug Abuse, the United States Food and Drug Administration, and the United States Drug Enforcement Administration. The board shall cause marijuana approved for use […]
Patient participants in the program are immune from state prosecution for possession of marijuana as authorized by this article and under the program established in this article. A person authorized under this program shall not possess an amount of marijuana in excess of the amount prescribed under the authority of this article. The amount prescribed […]
